Clinical Trial Update: CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes pediatric patients with relapsed/refractory CD19+ acute lymphoblastic leukemia and diffuse large B-cell lymphoma being trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Diffuse Large B-cell Lymphoma
• Mediastinal Lymphoma

Drugs mentioned

• CD19-CAR_Lenti T Cells

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING